share_log

NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi

NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi

NexImmune | 4:持股變動聲明-高管 Jones Kristi
美股SEC公告 ·  06/13 19:59

Moomoo AI 已提取核心訊息

NexImmune, Inc. President and CEO, Kristi Jones, completed a purchase of the company's stock on June 11, 2024. The transaction involved the acquisition of 1 share of NexImmune's Series A Preferred Stock at a price of $0.01 per share. Following the transaction, Jones holds a total of 1 share in direct ownership. The transaction reflects the executive's confidence in the company and provides investors with a signal of potential future performance.
NexImmune, Inc. President and CEO, Kristi Jones, completed a purchase of the company's stock on June 11, 2024. The transaction involved the acquisition of 1 share of NexImmune's Series A Preferred Stock at a price of $0.01 per share. Following the transaction, Jones holds a total of 1 share in direct ownership. The transaction reflects the executive's confidence in the company and provides investors with a signal of potential future performance.
2024年6月11日,NexImmune公司總裁兼首席執行官Kristi Jones以每股0.01美元的價格購買了1股NexImmune的A系列優先股。交易後,Jones直接擁有1股。該交易反映了該高管對公司的信懇智能,並向投資者發出潛在未來表現的信號。
2024年6月11日,NexImmune公司總裁兼首席執行官Kristi Jones以每股0.01美元的價格購買了1股NexImmune的A系列優先股。交易後,Jones直接擁有1股。該交易反映了該高管對公司的信懇智能,並向投資者發出潛在未來表現的信號。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息